Sarepta Therapeutics (NASDAQ:SRPT) Earns Peer Perform Rating from Analysts at Wolfe Research
Wolfe Research started coverage on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a research note issued to investors on Tuesday morning, MarketBeat reports. The brokerage issued a peer perform rating on the biotechnology company’s stock. A number of other equities research analysts also recently issued reports on SRPT. The Goldman Sachs Group lowered […]
Wolfe Research started coverage on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a research note issued to investors on Tuesday morning, MarketBeat reports. The brokerage issued a peer perform rating on the biotechnology company’s stock. A number of other equities research analysts also recently issued reports on SRPT. The Goldman Sachs Group lowered […]
